News Archives - Page 484 of 744

ThursdayJan 28, 2021 2:12 pm

Predictive Oncology (NASDAQ: POAI) Subsidiary Working to Individualize, Improve Ovarian Cancer Treatment Options

Ovarian cancer is a leading cause of death, causes more death than any other female reproductive system cancer POAI’s Helomics dedicated to improving clinical decision making for ovarian cancer patients Helomics has pioneered testing of drugs on patients’ own tumors to help oncologists individualize treatment options According to the American Cancer Society, an estimated 21,750 women received a new diagnosis of ovarian cancer this year, and almost 14,000 women will die from the disease (https://ibn.fm/4yfJn). Those numbers make ovarian cancer the fifth-leading cause of cancer deaths in women; ovarian cancer causes more deaths than any other cancer of the female reproductive…

ThursdayJan 28, 2021 11:43 am

Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Increases Private Placement, Begins Trading on OTC Market

Pure Extracts upsizes private placement to total 16,900,000 special warrants at price of $0.505. PULL also received approval from OTC Markets, is trading on OTC Market under ticker symbol PRXTF. Trading under new OTC ticker is “major step forward,” says Company CEO. Pure Extracts Technologies (CSE PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company, has increased its non-brokered private placement offering of special warrants; the original offering was announced on Dec. 16, 2020. The company also received approval from OTC Markets and is now trading on the OTC Market under the ticker symbol PRXTF. The Company observed that the…

WednesdayJan 27, 2021 3:45 pm

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Discusses Product Pipeline, Clinical Trial Plans, at H.C. Wainwright Bioconnect 2021 Virtual Conference

Company will initiate a Phase II adult trial for Berubicin this year focused on patients with glioblastoma multiforme WPD, a CNS sub-license partner, will be commencing a parallel Phase II adult trial and the first-ever pediatric Berubicin trial Additional clinical trials are in the pipeline, including one for the company’s newest drug candidate, WP1244, and its effects on central nervous system tumors Biopharmaceutical company CNS Pharmaceuticals (NASDAQ: CNSP) recently took part in the H.C. Wainwright Bioconnect 2021 Virtual Conference, which took place January 11-14, 2021. CNS’s CEO John Climaco gave a presentation at the event, discussing how the clinical-stage biopharmaceutical…

WednesdayJan 27, 2021 1:08 pm

Green Hygienics Holdings (GRYN) Leverages FDA Registration, USDA/CCOF Certification as Powerful Competitive Differentiator

Green Hygienics poised to become most highly certified hemp company in industry to differentiate itself from competition Anticipating tightening of regulatory standards, GRYN already achieved FDA registration and USDA/CCOF certification proving highest standards of product quality, transparency and safety With certifications to prove high-quality products, Green Hygienics appears ideally positioned to offer growth potential in increasingly quality-aware market As an innovative technology-driven enterprise, Green Hygienics Holdings (OTCQB: GRYN) is dedicated to delivering the highest operating standards of industrial hemp cultivation and processing, and manufacturing of pharmaceutical-grade bioactive cannabinoids. Poised to bring safe and consistent products to market and thus change…

TuesdayJan 26, 2021 2:44 pm

MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0) Well Placed as Agricultural Biopesticides Market Expected to Grow Rapidly

Research shows that market for agricultural biopesticides expected to grow rapidly at CAGR of 14.7% until 2025 MustGrow providing natural plant-based biopesticide solutions for protecting plants from pests and diseases, utilizing the natural defense mechanism of the mustard plant Company seems well positioned within biopesticides market expected to achieve fastest growth The market for agricultural biopesticides is growing rapidly. The latest Markets and Markets report estimated the industry was valued at $4.3 billion in 2020 and is projected to almost double its size in the next five years — reaching $8.5 billion by 2025 and growing at a CAGR of…

TuesdayJan 26, 2021 2:27 pm

PacRoots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) Leveraging Cannabis Market Shift by Producing “Super Elite” Strains

Rapidly growing cannabis market evolving to include diverse clientele seeking unique strains PACR uses genetics-first approach to cultivate exclusive high-yield strains with varying cannabinoid profiles PACR catalog features 350 tested cultivars, including 50 super-elite strains prized for unique properties Smoking marijuana decades ago traditionally meant rolling one type of cannabis that was grown outdoors under mostly natural conditions. Decades later, the market has completely transformed to accommodate the needs of savvy consumers who understand different strains and their varying effects. PacRoots Cannabis (CSE: PACR) (OTCQB: PACRF), a Canada-based cannabis company dedicated to producing premium-quality strains and products through a genetics-focused…

TuesdayJan 26, 2021 2:11 pm

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Enters 2021 with Optimism for Its Cancer Imaging Technology

Imagin Medical Inc. successfully weathered the 2020 pandemic-induced economic challenges and transitioned its surgical visualization product, the i/Blue Imaging System(TM) from the development stage to manufacturing and has after Imagin’s next stage will be supported by a $3 million convertible note, with the final funding tranche expected to close this quarter The i/Blue Imaging System combines the advantages of blue light with advanced optic and light sensors to address the limitations of both white and blue light imaging to help surgeons better visualize and remove cancerous cells. The system uses a contrast agent to highlight the cancer and projects both…

MondayJan 25, 2021 1:13 pm

United Medical Equipment Business Solutions Network Inc. Adds CareStart Antigen Test to List of COVID-19 Supplies

UME commited to offering high-quality COVID-19 services, solutions and supplies. To effectively end worldwide pandemic, systematic screening and detection of both clinical and asumptomatic COVID-19 tests is critical. CareStart antigen test features 10-minute processing time, identifies acute infection, helps provide critical answers. Despite approval and rollout of COVID-19 vaccines, experts agree that even as the pandemic dies down in the coming months, SARS-CoV-2, the virus that causes the infectious disease, is likely here for the long haul (https://ibn.fm/1idh8). United Medical Equipment Business Solutions Network ("UME") is here for the long haul too, commited to offering high-quality COVID-19 services, solutions and supplies.…

MondayJan 25, 2021 1:05 pm

Autonomous Security Robots Provide Safety, Stability During a Time of Economic Transition

Autonomous Security Robot (“ASR”) maker Knightscope offers a Machine-as-a-Service (“MaaS”) subscription that monitors, records and relays information according to business client needs Knightscope’s AI-enhanced robots patrol sites for Fortune 1000 companies, hospitals and police department clients, providing a sense of safety particularly in crime-prone areas The robots’ security features include 360-degree eye-level HD streaming video, obstacle recognition, face and license plate recognition, and thermal anomaly detection The Knightscope Security Operations Center (“KSOC”) allows operators to monitor real-time data produced by the robot patrols and to communicate with people through the robots’ Intercom and Broadcast system if necessary Market analysts foresee…

MondayJan 25, 2021 12:52 pm

Friendable Inc. (FDBL) Highlights Rapid Growth of Fan Pass Platform in Recap of 2020 Milestones

Friendable Inc.’s Fan Pass platform attracted a roster of more than 700 artists in 2020 Fan Pass is filling the void created by the live event shutdown necessitated by the COVID-19 pandemic New subscribers can check out the latest updates and releases from their favorite artists for free on a trial basis by downloading the Fan Pass app Friendable (OTC: FDBL), a mobile technology and marketing company focused on connecting and engaging users through its proprietary mobile and desktop applications, kicked off the new year by issuing a recap of its milestones and achievements in 2020. In the news release,…

Site Search

Company Search

Category: News